Is there an app that invests in healthcare and biotech stocks for me?

I'm Chris, one of the co-founders of Autopilot. Healthcare and biotech get lumped together, and they behave nothing alike.

A giant drugmaker and an early-stage biotech are both healthcare. One is steady. The other can double or halve on one trial. So here's how the healthcare Portfolios on Autopilot differ.

One thing first, because we're an SEC-registered investment adviser and I have to say it. Autopilot is the app. The actual investment advice comes from Autopilot Advisers, LLC. If you want the full legal version of anything in here, it's on our disclaimer page.

1) The biotech hedge fund tracker

The Biotech All-Star Tracker, from Jordan Grayson, an independent Pilot, is built on 13F filings from two biotech-focused hedge funds, Baker Bros. Advisors and Perceptive Advisors. The description says it takes the top 10 positions from each, forming a 20-stock Portfolio rebalanced after each new filing.

For those unaware, that means it follows what two specialist funds disclosed, 45 or more days after each quarter ends. It's covered in Jordan Grayson's Portfolios on Autopilot.

2) The industry-insider approach

Wolff's Medical Edge Fund, from Peter Wolff, an independent Pilot, is built on the idea that an investor's edge is in the industry they know, which for Peter is healthcare. Its page is Wolff's Medical Edge Fund.

3) The moat approach

The CTK Healthcare Fund, from CTK Capital Intelligence, an independent Pilot, holds five businesses with advantages money alone can't buy, like regulatory approval, licensed distribution, or high switching costs. The description's view is that an aging population, not the economy, sets healthcare demand.

4) The value approach, and the GLP-1 chain

Derek Quick's AI Safe Value Fund looks for healthcare companies, including GLP-1-related ones, that he believes are priced below their fundamentals. And SLIM, an Autopilot Portfolio, holds the whole GLP-1 chain in equal weights, covered in Is there an app that invests in GLP-1 and weight-loss drug stocks for me?.

5) The risk, said plainly

I want to be honest with you. Biotech can move enormously on a single clinical result, a regulatory decision, or a pricing change. Five-stock and 20-stock Portfolios feel that more than a broad fund would.

Figure out which kind of healthcare you actually want, steady or speculative, before you pick. Then check what each one holds in the app.

6) How following works

Pick a Portfolio, connect the brokerage you already use, and allocate money. You give Autopilot Advisers limited authority to send orders to the account you already have. When the Portfolio changes, we send them and your broker fills them. The money stays put.

A flat cash subscription, not a percentage of your balance. Per our Form CRS dated February 2026, Basic Tier has no Base Advisory and Licensing Fee, and Premium Tier is $29.99 to $199.99 a quarter or $99.99 to $699.99 a year. Pilot subscriptions are separate and add on for each Pilot you subscribe to. Because it's a flat dollar amount, it's a bigger share of a small account than a big one, so do the math at your balance.

TLDR: Healthcare Portfolios on Autopilot range from a biotech hedge fund tracker to an industry-insider fund, a five-stock moat Portfolio, a value approach, and a GLP-1 chain Portfolio. Biotech swings hard on single events, so decide steady or speculative first.

Frequently asked questions

Is there an app that invests in biotech stocks for me?

Yes. Autopilot has several, including a Portfolio built on two biotech hedge funds' 13F filings, a healthcare-insider Portfolio, a five-stock moat Portfolio, and a GLP-1 chain Portfolio. Each is described in the app.

biotech portfolio app

The biotech and healthcare Portfolios on Autopilot differ in approach: filings-based, industry-insider, moat-focused, value, and whole-chain. Biotech is volatile, so check how concentrated each one is.

Can I follow a biotech portfolio in my own brokerage account?

Yes. Pick one in the app, connect the brokerage you already use, and allocate money. When the Portfolio changes, Autopilot Advisers sends the orders and your broker fills them.

Start Investing

Since Autopilot Advisers is an SEC-registered investment adviser, we have to put disclaimers on stuff like this. They're below, and the full version is on our disclaimer page.

Disclosures

© Autopilot Holdings Corporation 2026 — All rights reserved. “Autopilot” refers to Autopilot Holdings Corporation and its wholly-owned, and separately managed subsidiaries, including Autopilot Advisers, LLC, an SEC-registered investment adviser. All investing is subject to investment risks, including possible loss of the principal invested, and past performance is not indicative of future results. View our Customer Relationship Summary and other important information at joinautopilot.com/disclaimer.

This information is provided by Autopilot for educational and illustrative purposes only and is not a recommendation, an offer to sell or the solicitation to buy any security. Autopilot relies on information from various sources believed to be reliable, including information from Clients, Pilots and other third parties, but cannot guarantee the accuracy or completeness of that information. Autopilot does not provide tax or legal advice and you are encouraged to consult with professionals before making investment decisions.

Autopilot is not affiliated with, sponsored, or endorsed by the companies listed, described, or featured on its site. Company logos or trademarks used do not imply endorsement and are the property of their respective owners.

Investing involves risk, including the possible loss of principal. Past performance does not guarantee future results. You should carefully consider your investment objectives, risk tolerance, and time horizon before investing through Autopilot.

Autopilot Advisers, LLC is an SEC-registered investment adviser. Registration as an investment adviser does not imply a certain level of skill or training. Additional information about Autopilot is available in our Form ADV Part 2A, available at adviserinfo.sec.gov or joinautopilot.com/adv.

Autopilot provides limited investment advisory services focused on Portfolio selection and suitability assessment. Our services are not intended to replace comprehensive financial planning. We recommend consulting with a qualified financial advisor regarding your complete financial situation.

This content is provided for educational and informational purposes only. It does not constitute investment, legal, or tax advice and should not be relied upon as the basis for any investment decision. You should consult with qualified professionals regarding your specific circumstances.

Autopilot does not provide tax, legal, or accounting advice. You should consult with qualified tax and legal professionals regarding your specific circumstances.

Autopilot does not hold client assets. All investments are held at the brokerage firm you select and connect to Autopilot. Your brokerage firm is responsible for trade execution, custody, and reporting. Autopilot is not responsible for your broker-dealer’s services, fees, or execution quality.

Autopilot’s services depend on technology systems, third-party APIs, and internet connectivity. System outages, API disruptions, or connectivity issues may temporarily affect service availability or trade execution timing.

Client account holdings are designed to track the Portfolio you’ve selected, but your actual holdings and performance may differ from the Portfolio due to execution timing, market conditions, brokerage capacity constraints, fractional share availability, and other factors outside Autopilot’s control.

For Portfolios inspired by publicly disclosed trading activity, there may be a delay between when a Pilot executes a trade and when that trade becomes publicly available and is incorporated into the Portfolio. This timing delay may affect the suitability or performance of trades when executed in client accounts.

Third-Party Pilot Portfolios are created and managed by independent third parties who are not affiliated with Autopilot, are not acting as your investment adviser, and owe you no fiduciary duty. Third-Party Pilots receive a share of the fees attributable to their Portfolios, which creates conflicts of interest for them and for Autopilot, and they may trade the same securities their Portfolios hold. Autopilot may convert a Third-Party Pilot Portfolio to an Autopilot Portfolio at any time.

Baker Bros. Advisors and Perceptive Advisors are not affiliated with Autopilot, do not manage these Portfolios, and have not endorsed them. SLIM is created and managed by Autopilot Advisers, LLC; it is general and impersonal in nature, and Autopilot may change or close it at any time. Healthcare and biotechnology securities can be highly volatile, including in response to clinical and regulatory events. Listing is not an endorsement of a Pilot or strategy. Fee amounts are quoted from Form CRS dated February 2026 and may change.